U.S. market Open. Closes in 4 hours 32 minutes

LAB | Standard BioTools Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue106.34M97.95M130.58M138.14M117.24M112.96M
Cost of Revenue55.89M60.90M61.21M54.82M52.96M51.31M
Gross Profit50.45M37.05M69.37M83.33M64.28M61.65M
Operating Expenses113.49M153.26M136.83M134.36M116.12M109.81M
Selling, General & Admin87.54M114.76M98.89M97.90M84.48M79.78M
Research & Development25.95M38.50M37.94M36.46M31.64M30.03M
Other Operating Expenses6.96M-12.31M7.63M507.00K1.43M637.00K
Operating Income-63.04M-116.20M-67.46M-51.04M-51.84M-48.16M
Other Expenses / Income-11.16M-76.72M3.80M-3.06M-14.87M637.00K
Before Tax Income-74.20M-192.93M-63.66M-54.10M-66.70M-61.42M
Income Tax Expenses452.00K-2.83M-4.42M-1.08M-1.92M-2.41M
Net Income-74.66M-190.10M-59.24M-53.02M-64.79M-59.01M
Interest Expenses4.57M4.33M3.82M3.57M4.28M13.89M
Basic Shares Outstanding79.16M78.31M75.79M72.04M66.78M39.65M
Diluted Shares Outstanding79.16M78.31M75.79M72.04M66.78M39.65M
EBITDA-47.86M-113.49M-44.26M-34.60M-34.60M-30.95M
EBITDA Margin-45.01%-115.87%-33.89%-25.05%-29.51%-27.40%
EBIT-69.64M-188.60M-59.84M-50.53M-62.43M-47.53M
EBIT Margin-65.49%-192.55%-45.82%-36.58%-53.24%-42.07%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙